ACA

NEUTRALM&A

Arcosa, Inc.

2026-09-09

Price

$145.39

-0.18%

This is the 2026-09-09 snapshot — the signals and analysis for ACA as of this single trading day.

View full ACA research hub →

Score11.5Top Tier

Signals7/8 DNA0/13 Act · 1/4 Risk

SentimentNEUTRALScore: 8

Volume1.3xvs 20d avg

Analysis

Arcosa's (ACA) price action is entirely dictated by its pending all-cash acquisition by CRH at $150 per share. The stock's ultra-low annualized volatility (2.7%) and tight technical clustering (PERFECT_STACK) are textbook signatures of a late-stage merger arbitrage setup, especially after ACA shareholders officially approved the deal on September 4th. Furthermore, the current RISK_ON macro regime—characterized by ultra-tight credit spreads (0.81%)—virtually eliminates deal-financing risk for the buyer, providing high institutional conviction that the remaining ~3.1% spread to the buyout price will be realized.

Fired Signals

ALPHA MALEQUIET STORMSTEADY CLIMBGOLDEN CROSSBOLLINGER SQUEEZEMARKET LEADERPERFECT STACKDISTRIBUTION

Key Takeaways

Actionable Thesis: Accumulate ACA to capture the ~3.1% merger arbitrage spread up to the $150 all-cash buyout price from CRH.
Key Risk: Unexpected antitrust or regulatory blocks from the FTC/DOJ that could delay or jeopardize the final closing.
What to Watch: Keep a close eye on the $144.90 technical floor; any breach signals potential deal trouble or institutional distribution.

← Back to 2026-09-09 View Full ACA History →Yahoo Finance &nearr;